1. Chronic Mesenteric Venous Thrombosis: Evaluation and Determinants of Survival During Long-Term Follow-up 
David W. Orr, Phillip M. Harrison, John Devlin, John B. Karani, Pauline A. Kane, Nigel D. Heaton, John G. O’Grady, Michael A. Heneghan 
Clinical Gastroenterology and Hepatology 
Volume 5, Issue 1, Pages (January 2007)
DOI: /j.cgh
Copyright © 2007 AGA Institute Terms and Conditions

2. Figure 1
Survival curves (in months) for patients with chronic PM or PSM venous thrombosis who received: (A) long-term anticoagulation or no anticoagulation (P < .05, log rank test) and (B) β-blockade or no β-blockade (P = .04, log-rank test). (A) (solid line), Coumadin; (broken line), no coumadin; (B) (solid line), β-blocker; (broken line), no β-blocker.
Clinical Gastroenterology and Hepatology 2007 5, 80-86DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions

3. Figure 2
Survival curves (in months) for patients with chronic PM or PSM venous thrombosis who received β-blocker monotherapy, coumadin monotherapy, or combination treatment vs no treatment (P < .05, log-rank test)., Coumadin (n = 8); – – – –, β-blockers (n = 25); -----, β-blockers and coumadin (n = 10;·····, no treatment (n = 17).
Clinical Gastroenterology and Hepatology 2007 5, 80-86DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions